Thuja Occidentalis Pellet
Product Images NDC 15631-0442

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Thuja Occidentalis (NDC 15631-0442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Pellets Fda 15631 0442

This is a description for Thuja Occidentalis, a medication used for temporary relief of warts. The medicine is taken orally, with adults advised to take 4-6 pellets three times daily, while children above the age of 2 take 12 pellets per thrice daily. The medicine contains both active and inactive ingredients such as sucrose, and should be used for self-limiting conditions. Additionally, if symptoms worsen after four days or fail to improve, it's recommended to discontinue using the medication and seek assistance from a healthcare professional. However, the given text seems incomplete and also contains errors.*

FDA Label Image

Mini Labels Pellets Fda15631 0442

This is a description of a homeopathic medicine that provides temporary relief. The active ingredient is THUJA OCCIDENTALIS 1X, and the inactive ingredient is sucrose. The medicine is available in pellet form and can be taken orally by adults and children aged 2 and above. The dosage instructions suggest taking 4 or pellets, three times a day or as directed by the physician. This medicine is homoeopathic and not regulated by the FDA. The label includes the product's NDC number, manufacturing date, and expiration date. The description further explains that the medicine comes in a blister pack and select pack sizes.*

FDA Label Image

Rxhomeo Secondary Packing Blister Pack

LACTOSE FREE product with an unreadable label attached. No further information is available.*

FDA Label Image

Rxhomeo Secondary Packing Carton Pack

This is a description of a single homeopathic remedy that is lactose-free and manufactured according to the Homoeopathic Pharmacopoeia of the United States (HPUS). The manufacturer is located in India and their US FDA Establishment number is printed on the product. The warning advises that the product should not be used for self-limiting conditions, and to seek assistance from a healthcare professional if symptoms do not improve in four days or worsen. The label advises to keep the medication out of reach of children and store it in a cool, dark place. The packaging may vary depending on the size of the bottle or container.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.